Scandinavian Biolabs ApS: Financial statements 2020
CVR: 41170514
Source: annual report 2020, Danish Business Authority
05/02/2020 – 31/12/2020
Scandinavian Biolabs ApS (CVR 41170514) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -1,145,354 and a net result of DKK -1,781,307. Equity in the 2020 report amounted to DKK -1,741,307. The company had 2 employees in the financial year.
- Gross Profit
- DKK -1,145,354
- Profit/Loss
- DKK -1,781,307
- Equity
- DKK -1,741,307
- Total Assets
- DKK 478,572
- Employees
- 2
Official annual report
How creditworthy is Scandinavian Biolabs ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of July 22, 2020, Christian Fogh Harboe is registered as director of Scandinavian Biolabs ApS.
As of June 2, 2020, BLAZAR ApS is registered as an owner of Scandinavian Biolabs ApS with an ownership share of 33%.
As of February 5, 2020, Christopher Nørgaard Haslund is registered as adm. dir. of Scandinavian Biolabs ApS.
Scandinavian Biolabs ApS was founded on February 5, 2020.
About Scandinavian Biolabs ApS
Scandinavian Biolabs ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Engroshandel med parfumerivarer og kosmetik. The management consists of Niels Valdemar Lundsgaard Konradi. The board consists of Mitesh Jatania (chair), Anders Reckendorff, Pascar Paw Paramasivam and Samuel Meeker Kaplan. The company's owners include Niels Valdemar Lundsgaard Konradi, Anders Reckendorff and BLAZAR ApS. The company has 19 employees (2026). In 2025, the company reported a gross profit of DKK -13,841,560 and a net result of DKK -25,270,973 compared with DKK -8,773,342 the year before. Equity in the 2025 report amounted to DKK 31,549,921.